rs3214021

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_018368.4(LMBRD1):​c.1509+22G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.399 in 1,599,476 control chromosomes in the GnomAD database, including 129,440 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.36 ( 10557 hom., cov: 31)
Exomes 𝑓: 0.40 ( 118883 hom. )

Consequence

LMBRD1
NM_018368.4 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.0240

Publications

7 publications found
Variant links:
Genes affected
LMBRD1 (HGNC:23038): (LMBR1 domain containing 1) This gene encodes a lysosomal membrane protein that may be involved in the transport and metabolism of cobalamin. This protein also interacts with the large form of the hepatitis delta antigen and may be required for the nucleocytoplasmic shuttling of the hepatitis delta virus. Mutations in this gene are associated with the vitamin B12 metabolism disorder termed, homocystinuria-megaloblastic anemia complementation type F.[provided by RefSeq, Oct 2009]
LMBRD1 Gene-Disease associations (from GenCC):
  • methylmalonic aciduria and homocystinuria type cblF
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, ClinGen, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 6-69676428-C-T is Benign according to our data. Variant chr6-69676428-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 261024.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.526 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LMBRD1NM_018368.4 linkc.1509+22G>A intron_variant Intron 15 of 15 ENST00000649934.3 NP_060838.3 Q9NUN5-1
LMBRD1NM_001363722.2 linkc.1290+22G>A intron_variant Intron 15 of 15 NP_001350651.1
LMBRD1NM_001367271.1 linkc.1290+22G>A intron_variant Intron 15 of 15 NP_001354200.1
LMBRD1NM_001367272.1 linkc.1290+22G>A intron_variant Intron 15 of 15 NP_001354201.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LMBRD1ENST00000649934.3 linkc.1509+22G>A intron_variant Intron 15 of 15 NM_018368.4 ENSP00000497690.1 Q9NUN5-1

Frequencies

GnomAD3 genomes
AF:
0.363
AC:
55037
AN:
151798
Hom.:
10549
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.238
Gnomad AMI
AF:
0.399
Gnomad AMR
AF:
0.391
Gnomad ASJ
AF:
0.443
Gnomad EAS
AF:
0.542
Gnomad SAS
AF:
0.445
Gnomad FIN
AF:
0.343
Gnomad MID
AF:
0.471
Gnomad NFE
AF:
0.409
Gnomad OTH
AF:
0.386
GnomAD2 exomes
AF:
0.403
AC:
100647
AN:
249472
AF XY:
0.410
show subpopulations
Gnomad AFR exome
AF:
0.230
Gnomad AMR exome
AF:
0.389
Gnomad ASJ exome
AF:
0.439
Gnomad EAS exome
AF:
0.550
Gnomad FIN exome
AF:
0.342
Gnomad NFE exome
AF:
0.406
Gnomad OTH exome
AF:
0.406
GnomAD4 exome
AF:
0.403
AC:
582655
AN:
1447558
Hom.:
118883
Cov.:
29
AF XY:
0.405
AC XY:
292179
AN XY:
721092
show subpopulations
African (AFR)
AF:
0.227
AC:
7511
AN:
33132
American (AMR)
AF:
0.390
AC:
17384
AN:
44600
Ashkenazi Jewish (ASJ)
AF:
0.445
AC:
11587
AN:
26020
East Asian (EAS)
AF:
0.545
AC:
21520
AN:
39470
South Asian (SAS)
AF:
0.445
AC:
38276
AN:
85960
European-Finnish (FIN)
AF:
0.352
AC:
18739
AN:
53302
Middle Eastern (MID)
AF:
0.457
AC:
2622
AN:
5740
European-Non Finnish (NFE)
AF:
0.401
AC:
440728
AN:
1099442
Other (OTH)
AF:
0.406
AC:
24288
AN:
59892
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
17976
35952
53929
71905
89881
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13564
27128
40692
54256
67820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.362
AC:
55066
AN:
151918
Hom.:
10557
Cov.:
31
AF XY:
0.361
AC XY:
26819
AN XY:
74228
show subpopulations
African (AFR)
AF:
0.238
AC:
9850
AN:
41418
American (AMR)
AF:
0.392
AC:
5974
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
0.443
AC:
1537
AN:
3472
East Asian (EAS)
AF:
0.543
AC:
2810
AN:
5174
South Asian (SAS)
AF:
0.446
AC:
2147
AN:
4816
European-Finnish (FIN)
AF:
0.343
AC:
3615
AN:
10534
Middle Eastern (MID)
AF:
0.476
AC:
140
AN:
294
European-Non Finnish (NFE)
AF:
0.409
AC:
27811
AN:
67940
Other (OTH)
AF:
0.389
AC:
819
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1777
3553
5330
7106
8883
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
544
1088
1632
2176
2720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.392
Hom.:
3921
Bravo
AF:
0.358
Asia WGS
AF:
0.476
AC:
1656
AN:
3476

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Mar 10, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Methylmalonic aciduria and homocystinuria type cblF Benign:1
Aug 19, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
1.7
DANN
Benign
0.28
PhyloP100
-0.024
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3214021; hg19: chr6-70386320; COSMIC: COSV65296527; API